Corticosteroid injections for knee osteoarthritis offer clinical benefits similar to hyaluronic acid and lower than platelet-rich plasma: a systematic review and meta-analysis
EFORT Open Reviews · 01.09.2024 · 9 (9) · 883-895
DOI: 10.1530/eor-23-0198 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift EFORT Open Reviews, erschienen am 01.09.2024. Verfasst von Alessandro Bensa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
Intra-articular corticosteroid (CS) injections for knee osteoarthritis (OA) management are endorsed by several scientific societies, while the use of hyaluronic acid (HA) and platelet-rich plasma (PRP) is more controversial. Aim of the study was to quantify and compare the clinical effectiveness of CS injections with respect to HA and PRP in patients with knee OA.
Methods
The search was conducted on PubMed, Cochrane, and Web of Science following the PRISMA guidelines. Randomized controlled trials (RCTs) on the comparison of CS injections and HA or PRP injections for the treatment of knee OA were included. The minimal clinically important difference (MCID) was used to interpret the clinical relevance of the improvements at different follow-ups up to 12 months. The study quality was assessed using the Cochrane RoB-2 tool and the GRADE guidelines.
Results
Thirty-five RCTs were included (3348 patients). The meta-analysis comparing CS and HA revealed no difference in terms of WOMAC improvement, while HA showed superior VAS pain improvement at long-term follow-up ( P = 0.011), without reaching the MCID. PRP offered a superior WOMAC improvement compared to CS at short- ( P = 0.002), mid- ( P < 0.001, exceeding the MCID), and long-term ( P < 0.001, exceeding the MCID) follow-ups. PRP offered a superior VAS improvement at mid- ( P < 0.001, exceeding the MCID) and long-term ( P = 0.023) follow-ups.
Conclusion
CS injections for knee OA offer similar results to HA and PRP only at short term, while there is an overall superiority of PRP at longer follow-ups. This difference is not only statistically significant but also clinically relevant in favour of PRP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland.
- Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
- Università della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.
ORCID-Profile: Alessandro Sangiorgio, Angelo Boffa, Manuela Salerno
Zitieren
APA
Bensa, A., Sangiorgio, A., Boffa, A., Salerno, M., Moraca, G., & Filardo, G. (2024). Corticosteroid injections for knee osteoarthritis offer clinical benefits similar to hyaluronic acid and lower than platelet-rich plasma: a systematic review and meta-analysis. EFORT Open Reviews, 9(9), 883-895. https://doi.org/10.1530/eor-23-0198
Vancouver
Bensa A, Sangiorgio A, Boffa A, Salerno M, Moraca G, Filardo G. Corticosteroid injections for knee osteoarthritis offer clinical benefits similar to hyaluronic acid and lower than platelet-rich plasma: a systematic review and meta-analysis. EFORT Open Reviews. 2024;9(9):883-895. doi:10.1530/eor-23-0198
BibTeX
@article{Bensa2024,
author = {Bensa, Alessandro and Sangiorgio, Alessandro and Boffa, Angelo and Salerno, Manuela and Moraca, Giacomo and Filardo, Giuseppe},
title = {Corticosteroid injections for knee osteoarthritis offer clinical benefits similar to hyaluronic acid and lower than platelet-rich plasma: a systematic review and meta-analysis},
journal = {EFORT Open Reviews},
year = {2024},
volume = {9},
number = {9},
pages = {883--895},
doi = {10.1530/eor-23-0198}
}
EUVIMED